Article info
PDFClinical and epidemiological research
Extended report
Efficacy and safety of adrenocorticotropic hormone gel in refractory dermatomyositis and polymyositis
- Correspondence to Dr Rohit Aggarwal, Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA 15217, USA; aggarwalr{at}upmc.edu
Citation
Efficacy and safety of adrenocorticotropic hormone gel in refractory dermatomyositis and polymyositis
Publication history
- Received July 10, 2017
- Revised November 27, 2017
- Accepted November 29, 2017
- First published December 13, 2017.
Online issue publication
October 31, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.